Juan-Manuel Sancho (J M Sancho, Juan Manuel Sancho)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 34

Top Venues

European journal of haematology

British journal of haematology

Cancers

Leukemia & lymphoma

This page only lists publications with an associated author ORCID identifier.

Publications

Minna Harmanen, Marc Sorigue, Madiha Khan, Roosa Prusila, Tuula Klaavuniemi, Esa Kari, Esa Jantunen, Kaisa Sunela, Aino Rajamäki, Erika Alanne, Hanne Kuitunen, Arja Jukkola, Juan-Manuel Sancho, Outi Kuittinen, Aino Rönkä
Front-line and second-line treatment for mantle cell lymphoma in clinical practice: A multicenter retrospective analysis. European journal of haematology 113 (2) (2024)
Juan-Manuel Sancho, Pau Abrisqueta, Abhijeet Kumar, Raul Cordoba, Monica Tani, Peter Langmuir, Erica Rappold, Teng Liu, Armondo López-Guillermo
Safety and efficacy of parsaclisib in combination with rituximab, bendamustine + rituximab, or ibrutinib in patients with previously treated B-cell lymphoma: analysis of a phase 1 dose-finding study (CITADEL‑112). Leukemia & lymphoma 65 (7) (2024)
Mariana Bastos-Oreiro, Antonio Gutierrez, Almudena Cabero, Javier López, Paola Villafuerte, Ana Jiménez-Ubieto, Raquel de Oña, Adolfo De la Fuente, Belén Navarro, Javier Peñalver, Pilar Martínez, Carmen Alonso, Maria Stefania Infante, Raul Cordoba, Blanca Perez-Montero, Jaime Pérez de Oteyza, Sonia González de Villambrosio, Paula Fernández-Caldas, Raquel Del Campo, Daniel García Belmonte, Javier Diaz-Gálvez, Antonio Salar-Silvestre, Juan-Manuel Sancho
Comparing R-Bendamustine vs. R-CHOP Plus Maintenance Therapy as First-Line Systemic Treatment in Follicular Lymphoma: A Multicenter Retrospective GELTAMO Study. Cancers 16 (7) (2024)
Juan-Manuel Sancho, Pau Abrisqueta, Abhijeet Kumar, Raul Cordoba, Monica Tani, Peter Langmuir, Erica Rappold, Teng Liu, Armondo López-Guillermo
Safety and efficacy of parsaclisib in combination with rituximab, bendamustine + rituximab, or ibrutinib in patients with previously treated B-cell lymphoma: analysis of a phase 1 dose-finding study (CITADEL‑112). Leukemia & lymphoma (2024)
Minna Harmanen, Marc Sorigue, Madiha Khan, Roosa Prusila, Tuula Klaavuniemi, Esa Kari, Esa Jantunen, Kaisa Sunela, Aino Rajamäki, Erika Alanne, Hanne Kuitunen, Arja Jukkola, Juan-Manuel Sancho, Outi Kuittinen, Aino Rönkä
Front-line and second-line treatment for mantle cell lymphoma in clinical practice: A multicenter retrospective analysis. European journal of haematology 113 (2) (2024)
Mariana Bastos-Oreiro, Antonio Gutierrez, Almudena Cabero, Javier López, Paola Villafuerte, Ana Jiménez-Ubieto, Raquel de Oña, Adolfo De la Fuente, Belén Navarro, Javier Peñalver, Pilar Martínez, Carmen Alonso, Maria Stefania Infante, Raul Cordoba, Blanca Perez-Montero, Jaime Pérez de Oteyza, Sonia González de Villambrosio, Paula Fernández-Caldas, Raquel Del Campo, Daniel García Belmonte, Javier Diaz-Gálvez, Antonio Salar-Silvestre, Juan-Manuel Sancho
Comparing R-Bendamustine vs. R-CHOP Plus Maintenance Therapy as First-Line Systemic Treatment in Follicular Lymphoma: A Multicenter Retrospective GELTAMO Study. Cancers 16 (7) (2024)
Mariana Bastos-Oreiro, Antonio Gutierrez, Almudena Cabero, Javier López, Paola Villafuerte, Ana Jiménez-Ubieto, Raquel de Oña, Adolfo De la Fuente, Belén Navarro, Javier Peñalver, Pilar Martínez, Carmen Alonso, Maria Stefania Infante, Raul Cordoba, Blanca Perez-Montero, Jaime Pérez de Oteyza, Sonia González de Villambrosio, Paula Fernández-Caldas, Raquel Del Campo, Daniel García Belmonte, Javier Diaz-Gálvez, Antonio Salar-Silvestre, Juan-Manuel Sancho
Comparing R-Bendamustine vs. R-CHOP Plus Maintenance Therapy as First-Line Systemic Treatment in Follicular Lymphoma: A Multicenter Retrospective GELTAMO Study. Cancers 16 (7) (2024)
Minna Harmanen, Marc Sorigue, Madiha Khan, Roosa Prusila, Tuula Klaavuniemi, Esa Kari, Esa Jantunen, Kaisa Sunela, Aino Rajamäki, Erika Alanne, Hanne Kuitunen, Arja Jukkola, Juan-Manuel Sancho, Outi Kuittinen, Aino Rönkä
Front-line and second-line treatment for mantle cell lymphoma in clinical practice: A multicenter retrospective analysis. European journal of haematology (2024)
Juan-Manuel Sancho, Marc Sorigué, Eva Rubio-Azpeitia
Real-World Evidence of Relapsed/Refractory Mantle Cell Lymphoma Patients and Treatments: A Systematic Review. Journal of blood medicine 15 (2024)
Juan-Manuel Sancho, Marc Sorigué, Eva Rubio-Azpeitia
Real-World Evidence of Relapsed/Refractory Mantle Cell Lymphoma Patients and Treatments: A Systematic Review. Journal of blood medicine 15 (2024)
Juan-Manuel Sancho, Pau Abrisqueta, Abhijeet Kumar, Raul Cordoba, Monica Tani, Peter Langmuir, Erica Rappold, Teng Liu, Armondo López-Guillermo
Safety and efficacy of parsaclisib in combination with rituximab, bendamustine + rituximab, or ibrutinib in patients with previously treated B-cell lymphoma: analysis of a phase 1 dose-finding study (CITADEL‑112). Leukemia & lymphoma 65 (7) (2024)
Aino Rajamäki, Mika Hujo, Reijo Sund, Roosa Enni Inkeri Prusila, Milla E L Kuusisto, Hanne Kuitunen, Esa Jantunen, Santiago Mercadal, Marc Sorigue, Juan-Manuel Sancho, Kaisa Sunela, Outi Kuittinen
Estimating the Lifetime Treatment Burden of Patients With Follicular Lymphoma: A Retrospective Study Using Real-World Multicenter Data. JCO clinical cancer informatics 7 (2023)
Alejandro Martin Martin Garcia-Sancho, M Baile, G Rodríguez, Ivan Dlouhy, Juan-Manuel Sancho, I Jarque, E González-Barca, A Salar, M Espeso, C Grande, Juan-Miguel Bergua, S Montes-Moreno, A Redondo, A Enjuanes, E Campo, Armondo López-Guillermo, D Caballero
Lenalidomide in combination with R-ESHAP in patients with relapsed or refractory diffuse large B-cell lymphoma: A phase 2 study from GELTAMO. British journal of haematology (2023)
Marta Canelo-Vilaseca, Gustavo Tapia, Elisa Orna, Marc Sorigué, Isabel Granada, Azahara Palomar-Muñoz, Ana Castillo, Javier Grau, Alba Mesa, Josep-María Ribera, Juan-Manuel Sancho, Jose-Tomás Navarro
HHV8 and EBV-negative primary effusion-based lymphoma: A case report of a new provisional entity and review of literature. Clinical case reports 11 (5) (2023)
Ana Muntañola, María Teresa Villalobos, Sonia González-Villambrosia, María José Rodríguez-Salazar, Ana Jiménez-Ubieto, Gabriela Bastidas-Mora, Raul Cordoba, María Infante, María Jesús Vidal, Francisco Javier Díaz, Mónica Baile, Mariana Bastos-Oreiro, Carlos Panizo, Juan-Manuel Sancho, Belén Navarro, Tomás García, Lourdes Escoda, Pau Abrisqueta, María José Terol, Raquel de Campo, Pablo Mozas, Armondo López-Guillermo, Antonio Salar-Silvestre, Carlos Montalbán, null null
Low-risk HPLLs/ABC score patients with splenic marginal zone lymphoma can be safely managed without treatment: Results from a prospective Spanish study. British journal of haematology (2023)
Mehdi Hamadani, Morton Coleman, Ralph Boccia, Juraj Duras, Martin Hutchings, Pier Luigi Luigi Zinzani, Raul Cordoba, Mariana Bastos Oreiro, Vanessa Williams, Huiqing Liu, Michael Stouffs, Peter Langmuir, Juan-Manuel Sancho
Safety and efficacy of parsaclisib in combination with obinutuzumab and bendamustine in patients with relapsed or refractory follicular lymphoma (CITADEL-102): A phase 1 study. Hematological oncology (2023)
Marta Canelo-Vilaseca, Gustavo Tapia, Elisa Orna, Marc Sorigué, Isabel Granada, Azahara Palomar-Muñoz, Ana Castillo, Javier Grau, Alba Mesa, Josep-María Ribera, Juan-Manuel Sancho, Jose-Tomás Navarro
HHV8 and EBV-negative primary effusion-based lymphoma: A case report of a new provisional entity and review of literature. Clinical case reports 11 (5) (2023)
Ana Muntañola, Pablo Mozas, Santiago Mercadal, Maria Huguet, Sabela Bobillo, Mariana Bastos-Oreiro, Ana Jiménez-Ubieto, Jordina Rovira, Andrea Rivero, Carles Tolosa, Luis Luizaga, Sonia González de Villambrosia, Silvana Novelli, Dolores Caballero, Antonio Salar, Sara Alonso-Álvarez, Laura Magnano, Norma C Gutiérrez, Juan-Manuel Sancho, Armondo López-Guillermo, null null
Early progression in follicular lymphoma in the absence of histological transformation or high-risk Follicular Lymphoma International Prognostic Index still has a favourable outcome. British journal of haematology (2022)
Josée J M Zijlstra-Baalbergen, George Follows, René-Olivier Casasnovas, Joost S P Vermaat, Nagesh Kalakonda, Sylvain Choquet, Brian Hill, Catherine Thieblemont, Federica Cavallo, Fatima De la Cruz, John Kuruvilla, Nada Hamad, Ulrich Jaeger, Paolo Caimi, Ronit Gurion, Krzysztof Warzocha, Sameer Bakhshi, Juan-Manuel Sancho, Michael Schuster, Miklos Egyed, Fritz Offner, Theodoros P Vassilakopoulos, Priyanka Samal, Matthew Ku, Jenny Xu, Kelly Corona, Kamal Chamoun, Jatin Shah, Miguel Canales, Marie Maerevoet
The Association between Patient Characteristics and the Efficacy and Safety of Selinexor in Diffuse Large B-Cell Lymphoma in the SADAL Study. Cancers 14 (3) (2022)
Juan-Manuel Sancho, Ana Marín-Niebla, Silvia Fernández, Francisco-Javier Capote, Carolina Cañigral, Carlos Grande, Eva Donato, Izaskun Zeberio, Jose-Manuel Puerta, Alfredo Rivas, Elena Pérez-Ceballos, Ana Vale, Alejandro Martín García-Sancho, Antonio Salar, Eva González-Barca, Anabel Teruel, Carmen Pastoriza, Diego Conde-Royo, Joaquín Sánchez-García, Cristina Barrenetxea, Reyes Arranz, José-Ángel Hernández-Rivas, María-José Ramírez, Aroa Jiménez, Eva Rubio-Azpeitia
IBRORS-MCL study: a Spanish retrospective and observational study of relapsed/refractory mantle-cell lymphoma treated with ibrutinib in routine clinical practice. International journal of hematology 116 (3) (2022)
Sarah Bailly, Guillaume Cartron, Sridhar Chaganti, Raul Cordoba, Paolo Corradini, Johannes Düll, Isacco Ferrarini, Wendy Osborne, Andreas Rosenwald, Juan-Manuel Sancho, Herve Tilly, Eric Van Den Neste, Andreas Viardot, Chiara Rusconi
Targeting CD19 in diffuse large B-cell lymphoma: An expert opinion paper. Hematological oncology 40 (4) (2022)
Aino Rajamäki, Mika Hujo, Reijo Sund, Roosa Enni Inkeri Prusila, Milla E L Kuusisto, Hanne Kuitunen, Esa Jantunen, Santiago Mercadal, Marc Sorigue, Juan-Manuel Sancho, Outi Kuittinen, Kaisa Sunela
Link between disease status at 24 months and mortality in follicular lymphoma. British journal of haematology 199 (3) (2022)
Minna Harmanen, Mika Hujo, Reijo Sund, Marc Sorigue, Madiha Khan, Roosa Enni Inkeri Prusila, Tuula Klaavuniemi, Esa Kari, Esa Jantunen, Kaisa Sunela, Aino Rajamäki, Erika Alanne, Hanne Kuitunen, Juan-Manuel Sancho, Arja Jukkola, Aino Rönkä, Outi Kuittinen
Survival of patients with mantle cell lymphoma in the rituximab era: Retrospective binational analysis between 2000 and 2020. British journal of haematology (2022)
Georg Hess, Martin Dreyling, Lucie Oberic, Eva Gine, Pier Luigi Luigi Zinzani, Kim Linton, Adam Vilmar, Mats Jerkeman, Jenny M H Chen, Anke Ohler, Stephan Stilgenbauer, Catherine Thieblemont, Jonathan Lambert, Vittorio Ruggero Zilioli, Juan-Manuel Sancho, Ana Jiménez-Ubie, Luca Fischer, Toby Andrew Eyre, Sam Keeping, Julie E Park, James J Wu, Rubina Siddiqi, John Reitan, Sally Wade, Gilles Salles
Real-world experience among patients with relapsed/refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor failure in Europe: The SCHOLAR-2 retrospective chart review study. British journal of haematology (2022)
Christian Buske, Wojciech Jurczak, Juan-Manuel Sancho, Edvard Zhavrid, Jin Seok Kim, Jose-Ángel Hernández-Rivas, Aliaksandr Prokharau, Mariana Vasilica, Rajnish Nagarkar, Larry Kwak, Won-Seog Kim, Sang Joon Lee, SungHyun Kim, KeumYoung Ahn, Michinori Ogura
Long-term efficacy and safety of CT-P10 or rituximab in untreated advanced follicular lymphoma: a randomized phase 3 study. Blood advances 5 (17) (2021)
Gloria Iacoboni, Guillermo Villacampa, Nuria Martinez-Cibrian, Rebeca Bailén, Lucia Lopez Corral, Jose M Sanchez, Manuel Guerreiro, Ana Carolina Caballero, Alberto Mussetti, Juan-Manuel Sancho, Rafael Hernani, Pau Abrisqueta, Carlos Solano, Anna Sureda, Javier Briones, Alejandro Martin Garcia-Sancho, Mi Kwon, Juan Luis Reguera-Ortega, Pere Barba, null null
Real-world evidence of tisagenlecleucel for the treatment of relapsed or refractory large B-cell lymphoma. Cancer medicine 10 (10) (2021)
Juan-Manuel Sancho, Rubén Fernández-Alvarez, Francisco Gual-Capllonch, Esther González-García, Carlos Grande, Norma Gutiérrez, María-Jesús Peñarrubia, Ana Batlle-López, Eva González-Barca, José-María Guinea, Eva Gimeno, Francisco-Javier Peñalver, Miguel Fuertes, Mariana Bastos-Oreiro, José-Ángel Hernández-Rivas, José-María Moraleda, Olga García, Marc Sorigué, Alejandro Martin
R-COMP versus R-CHOP as first-line therapy for diffuse large B-cell lymphoma in patients ≥60 years: Results of a randomized phase 2 study from the Spanish GELTAMO group. Cancer medicine 10 (4) (2021)
Maria Concepción Fernández-Rodríguez, Juan José Rodríguez-Sevilla, Lierni Fernández-Ibarrondo, Blanca Sanchez-Gonzalez, Joan Gibert, Leyre Bento, Juan Fernando García, Juan-Manuel Sancho, Ramón Diez-Feijóo, Laura Camacho, Montserrat García-Retortillo, Eva Gimeno, Lluís Colomo, Antonio Gutierrez, Beatriz Bellosillo, Antonio Salar
Worse outcome and distinct mutational pattern in follicular lymphoma with anti-HBc positivity. Blood advances (2021)
Ivan Dlouhy, Kennosuke Karube, Anna Enjuanes, Itziar Salaverria, Ferran Nadeu, Juan Enric Ramis-Zaldivar, Juan G Valero, Alfredo Rivas-Delgado, Laura Magnano, David Martin-García, Patricia Pérez-Galán, Guillem Clot, Jordina Rovira, Pedro Jares, Olga Balagué, Eva Giné, Pablo Mozas, Javier Briones, Juan-Manuel Sancho, Antonio Salar, Santiago Mercadal, Miguel Alcoceba, Alexandra Valera, Elías Campo, Armondo López-Guillermo
Revised International Prognostic Index and genetic alterations are associated with early failure to R-CHOP in patients with diffuse large B-cell lymphoma. British journal of haematology (2021)
Cristina de-la-Fuente, Fidel Nuñez, Montserrat Cortés-Romera, Mireia Franch-Sarto, Josep-Maria Ribera, Juan-Manuel Sancho
Pembrolizumab for refractory primary mediastinal B-cell lymphoma with central nervous system involvement. Hematological oncology 39 (3) (2021)
Pablo Mozas, Marc Sorigue, Alfredo Rivas-Delgado, Andrea Rivero, Juan Gonzalo Correa, Carlos Castillo, Ferran Nadeu, Alex Bataller, Eva Giné, Tycho Baumann, Julio Delgado, Neus Villamor, Elias Campo, Laura Magnano, Juan-Manuel Sancho, Armondo López-Guillermo
The interval between frontline treatment and the second relapse (PFS2) predicts survival from the second relapse in follicular lymphoma patients. European journal of haematology 106 (3) (2020)
Antonio Gutierrez, Leyre Bento, Antonio Diaz-Lopez, Gilberto Barranco, Marta Garcia-Recio, Armando Lopez-Guillermo, Ivan Dlouhy, Jordina Rovira, Mario Rodriguez, Jose María Sanchez Pina, Monica Baile, Alejandro Martín, Silvana Novelli, Juan-Manuel Sancho, Olga García, Antonio Salar-Silvestre, Mariana Bastos-Oreiro, Mª José Rodriguez-Salazar, Ruben Fernandez, Fatima de la Cruz, Jose Antonio Queizan, Sonia González de Villambrosia, Raul Cordoba, Andres López, Hugo Luzardo, Daniel García, Jordi Sastre-Serra, Juan Fernando Garcia, Carlos Montalban, Fernando Cabanillas, Jose Rodríguez
Evaluation of the MD Anderson tumor score for diffuse large B-cell lymphoma in the rituximab era. European journal of haematology 104 (5) (2020)
Juan-Manuel Sancho, Belén Navarro, Joan Alfons Soler Campos, Jaime Pérez de Oteyza, Cristina de Barrenetxea Lekue, Marco Bregni, Silvina Grasso Cicala, Mario Spione, Cristina Mombiedro, Begoña Soler, Pier Luigi Zinzani
Efficacy and safety of pixantrone for the treatment of multiply relapsed or refractory aggressive non-Hodgkin B-cell lymphomas. European journal of haematology 104 (5) (2020)
Santiago Mercadal, Juan-Manuel Sancho, Fina Climent, Gustavo Tapia, Helena Pomares, Itziar Carro, Marc Sorigué, Maria Pané, Eva Domingo-Doménech, Maite Encuentra, Carmen Aguilera, Ana Carla Oliveira, Marcio Andrade, Alberto Fernández de Sevilla, Josep Maria Ribera, Eva González-Barca, Anna Sureda
Long-term outcome comparing histological grades of follicular lymphoma patients treated with immunochemotherapy as first-line therapy: A retrospective analysis from two institutions. European journal of haematology 104 (3) (2019)

Juan-Manuel Sancho.css-eqlu8i{font-size:small;padding-left:4px;} (J M Sancho, Juan Manuel Sancho)

Publication Activity (10 Years)

Top Topics

Top Venues

Juan-Manuel Sancho (J M Sancho, Juan Manuel Sancho)